Detalhe da pesquisa
1.
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study.
Atherosclerosis
; 331: 20-27, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303265